Announcement of The Consolidated Financial Report for The 1st Quarter of 2021
2021.5.6
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2021/05/06 | Time of announcement | 17:50:47 |
| Subject | Announcement of The Consolidated Financial Report for The 1st Quarter of 2021 | ||||
| Date of events | 2021/05/06 | To which item it meets | paragraph 31 | ||
| Statement | 1.Date of the financial reports submitted to the board of directors or approved by the board of directors:2021/05/06 2.Date of the financial reports approved by the audit committee:2021/05/06 3.Start and end dates of financial reports of the reporting period:2021/01/01~2021/03/31 4.Operating revenue accumulated from 1/1 to end of the period (thousand NTD):964,056 5.Gross profit (loss) from operations accumulated from 1/1 to end of the period (thousand NTD):611,251 6.Net operating income (loss) accumulated from 1/1 to end of the period (thousand NTD):219,162 7.Profit (loss) before tax accumulated from 1/1 to end of the period (thousand NTD):253,043 8.Profit (loss) accumulated from 1/1 to end of the period (thousand NTD):201,850 9.Profit (loss) during the period attributable to owners of parent accumulated from 1/1 to end of the period (thousand NTD):203,144 10.Basic earnings (loss) per share accumulated from 1/1 to end of the period (NTD):0.82 11.Total assets end of the period (thousand NTD):9,509,243 12.Total liabilities end of the period (thousand NTD):3,236,123 13.Equity attributable to owners of parent end of the period (thousand NTD):5,626,206 14.Any other matters that need to be specified:None |
||||